Literature DB >> 32411225

Feasibility of Attachable Ring Stimulator for Intraoperative Neuromonitoring during Thyroid Surgery.

Jongjin Kim1, Hyeon Jong Moon2, Young Jun Chai1, Jung-Man Lee3, Ki-Tae Hwang1, Che-Wei Wu4, Gianlorenzo Dionigi5, Hoon Yub Kim6, Kyung Sik Park7, Sang Wan Kim8, Ka Hee Yi8.   

Abstract

OBJECTIVE: Stimulator-attached dissecting instruments are useful for intraoperative nerve monitoring during thyroidectomy. The aim of this study was to evaluate the feasibility of an attachable ring stimulator (ARS) by comparing the electromyography (EMG) amplitudes evoked by an ARS and a conventional stimulator.
METHODS: Medical records of fourteen patients who underwent thyroidectomy using intraoperative neuromonitoring between June and August 2019 were retrospectively reviewed. The amplitudes of V1, R1, R2, and V2 signals were checked using both the ARS and a conventional stimulator, at the same point.
RESULTS: Both stimulators were tested on 20 recurrent laryngeal nerves (RLNs) and 20 vagus nerves (VNs). In all the nerves, the amplitudes of V1, R1, R2, and V2 were greater than 500 μV. The mean amplitudes of V1, R1, R2, and V2 checked with the ARS were 1175, 1432, 1598, and 1279 μV, respectively. The mean amplitudes of V1, R1, R2, and V2 checked with the conventional stimulator were 1140, 1425, 1557, and 1217 μV, respectively. Difference between amplitudes evoked by the two stimulators for V1, R1, R2, and V2 was 77, 110, 102, and 99 μV, respectively. There was no statistical difference in the amplitudes between the two groups for V1, R1, R2, and V2.
CONCLUSION: The ARS transferred electric stimulation as effectively as the conventional stimulator. It is an effective tool for repeated stimulation and facilitates continuous feedback regarding the functional integrity of nerves during thyroid surgery.
Copyright © 2020 Jongjin Kim et al.

Entities:  

Year:  2020        PMID: 32411225      PMCID: PMC7204267          DOI: 10.1155/2020/5280939

Source DB:  PubMed          Journal:  Int J Endocrinol        ISSN: 1687-8337            Impact factor:   3.257


1. Introduction

One of the most common surgical complications of thyroid surgery is recurrent laryngeal nerve (RLN) injury. The incidence of transient palsy is reported to be as high as 5.2% and as high as 3.6% for permanent palsy [1, 2]. Although identification of the RLN is a routine and safe procedure, it is often difficult to evaluate the intactness of the RLN by naked eye visualization [3]. Therefore, since 1970, in bilateral procedures, it has been recommended that the contralateral lobe should not be resected until the integrity of the RLN has been confirmed by stimulation with an electrical current [4]. Nowadays, intraoperative neuromonitoring (IONM) is widely employed in thyroid surgery to monitor the functional intactness of the RLN and vagus nerve (VN). In thyroid surgery, RLN injury occurs most frequently during traction of the thyroid gland or dissection of the soft tissue surrounding the RLN. Excessive traction on the thyroid can result in stretch injury of the RLN by Berry's ligament. Using energy-based devices for soft tissue dissection can cause thermal injury to the RLN [5, 6]. Using intermittent IONM (I-IONM), nerve function can be evaluated only when the nerve is stimulated, but not during surgical maneuvers between stimulations. Therefore, nerve injury cannot be avoided because nerve injury can only be detected after the injury has occurred. Recently, we adopted the use of an attachable ring stimulator (ARS; product name: stimulating ring electrode; product number: RSE1000; Medtronic, FL, Figure 1). During RLN dissection, the ARS was connected to mosquito forceps and continuously delivered an electric current to the RLN. The aim of the study was to evaluate the feasibility of the ARS by comparing the electromyography (EMG) amplitude of the vocal cord evoked by both the conventional stimulator (Figure 2, Prass Standard Monopolar Stimulator Probe, Medtronic, FL) and the ARS.
Figure 1

An attachable ring stimulator with a rubber ring for tightening (red arrow) (a). An attachable ring stimulator attached to mosquito forceps (b).

Figure 2

Conventional stimulator.

2. Materials and Methods

2.1. Patients

The medical records of patients who underwent thyroidectomy using I-IONM between June and August 2019 at Seoul Metropolitan Government-Seoul National University Boramae Medical Center were retrospectively reviewed. Surgery was performed by a single surgeon (Y. J. C). The institutional review board at Seoul Metropolitan Government-Seoul National University Boramae Medical Center approved this study (IRB no. L-2019-132).

2.2. Anesthesiology and Monitoring Setup

Anesthesia was induced with glycopyrrolate (0.2 mg), lidocaine (30 mg), propofol (1.5 mg/kg), and fentanyl (100 μg). After confirming loss of consciousness, rocuronium (0.3 ≥ 0.6 mg/kg) was administered for muscle relaxation. A pillow was placed beneath the neck for neck extension, prior to intubation, to avoid tube displacement during patient positioning. Then, a NIM® EMG endotracheal tube (Medtronic, FL) was inserted for IONM (Figure 3). The electrode on the EMG endotracheal tube was positioned 1.5 cm below the arytenoid cartilage so that the electrode would be situated at the level of the vocal cord. Sugammadex (1 mg/kg) was administered to reverse the neuromuscular blockage effect of rocuronium. Anesthesia was maintained with a continuous infusion of propofol and remifentanil using a target-controlled infusion system. All anesthetic procedures were performed or supervised by a single anesthesiologist (J. L).
Figure 3

Prior to intubation, a pillow was placed beneath the neck for neck extension to avoid tube displacement during patient positioning.

All setup and monitoring were performed in compliance with the standards outlined in the International Neural Monitoring Study Group (INMSG) guidelines [7]. Stimulation duration was set at 100 ms, the event threshold at 100 mV, and the stimulus current at 1 mA, with a frequency of 4 Hz. The RLN was considered to be successfully stimulated when the EMG amplitude was above 500 μV during stimulation. Troubleshooting algorithms provided in the INMSG guideline 2018 were applied if the EMG amplitude was below 500 μV [8]. For each surgery, the largest EMG amplitudes during stimulation were recorded.

2.3. Intraoperative Neuromonitoring Procedures

All patients underwent indirect laryngoscopic vocal cord examination and evaluation before and after thyroid lobectomy. During surgery, the ARS was attached to mosquito forceps for nerve stimulation. According to IONM guidelines, signals were recorded as follows: EMG amplitudes of the V1 (VN signal before surgical dissection), R1 (RLN signal at initial identification), R2 (RLN signal after thyroid removal and hemostasis), and V2 (VN signal after thyroid removal and hemostasis) [9]. In each patient, the carotid sheath was opened and the VN was fully exposed before testing V1 and the RLN was also fully exposed before testing R1. After the thyroid gland removal, the EMG amplitudes of the R2 and V2 signals were checked. V1, R1, R2, and V2 were checked using both the ARS and the conventional stimulator, at the same point, to compare the amplitudes evoked by each of the stimulators.

2.4. Statistics

Statistical analysis was performed using IBM SPSS Statistics for Windows, Version 20 (Armonk, NY: IBM Corp.). For continuous variables, data were expressed as mean ± standard deviation, and Student's t-test was used to compare the data between groups.

3. Results

Fifteen patients (1 males, 14 females) were included in this study (Table 1). Both an ARS and a conventional stimulator were tested on 40 nerves (20 RLN, 20 VN). The mean age of the patients was 48.1 ± 14.9 years. Mean tumor size was 1.5 ± 0.8 cm. Ten patients underwent thyroid lobectomy, and five patients underwent total thyroidectomy. No patient had vocal cord palsy on postoperative indirect laryngoscopic examination. Intraoperative neuromonitoring was successfully conducted in all patients, without any technical failure.
Table 1

Clinicopathological characteristics and surgical outcomes of the patients.

VariablesValues
Gender (male : female)1 : 14
Age (mean ± SD), years48.1 ± 14.9
Tumor size (mean ± SD), cm1.5 ± 0.8
Pathology
 Papillary thyroid carcinoma13
 Follicular adenoma2
Operative extent
 Lobectomy10
 Total thyroidectomy5
Vocal cord palsy0

MRND; modified radical neck dissection.

Table 2 demonstrates the EMG amplitude profiles of the RLN and VN stimulated by the ARS and the conventional stimulator. The mean amplitudes evoked by the ARS and the conventional stimulator were 1175 ± 658 μV and 1140 ± 650 μV for the V1, 1432 ± 789 μV and 1425 ± 763 μV for the R1, 1598 ± 828 μV and 1557 ± 830 μV for the R2, and 1279 ± 716 μV and 1217 ± 679 μV for the V2 signal. There was no statistical difference in the amplitudes between the two groups for V1 (p=0.867), R1 (p=0.979), R2 (p=0.876), and V2 (p=0.782). The mean difference between the amplitudes evoked by the two stimulators for V1, R1, R2, and V2 was 77 ± 114 μV (range 5 to 530), 110 ± 152 μV (range 2 to 670), 102 ± 103 μV (range 6 to 3639), and 99 ± 79 μV (range 1 to 372), respectively.
Table 2

EMG amplitude profiles of recurrent laryngeal nerve and vagus nerve stimulated by the attachable ring stimulator and conventional stimulator.

Patient no.SideV1 (μV)R1 (μV)R2 (μV)V2 (μV)
RingConventionalDiifRingConventionalDiifRingConventionalDiifRingConventionalDiif
1Rt21772077100257224061662361246099226622624
Lt1128117749184317331102178253035215631191372
2Lt15331003530110317736701587163548996107377
3Lt173515811542599247412526582487171218221766
4Lt1021102651375139217121612412586494985
5Rt64167736730809797706997174365489
6Rt10319775422782188901992179919312141111103
7Rt30043043392849280940263625835327712539232
Lt156115055614691518491741158415716361774138
8Lt76280846541566258348501656157110
9Rt6216401971680185146013561041219115762
10Rt66065377887862862902406906891
Lt1026105832956981256506034766863434
11Rt2100215959282727359236393633627812595186
12Lt607628211040103822403204036314871255232
13Lt8496971521050727323945818127705546159
14Rt594525697385781609679531479175734
Lt1146119549166617468013911356351177108493
15Rt76079232730693378797849572076848
Lt54157938761747147948243053755720
Mean117511407714321425110159815571021279121799
p value0.8670.9790.8760.782

∗Difference between the amplitudes evoked by the attachable ring stimulator and conventional stimulator. †p value for the mean amplitudes between the two groups.

4. Discussion

Intermittent IONM is a significant modality for monitoring RLN and VN functions during thyroid surgery, and it predicts postoperative vocal cord function well. However, there is no evidence that the use of I-IONM reduces the incidence of RLN injury during thyroid surgery. One possible explanation for this is that I-IONM does not provide real-time feedback about RLN or VN function during surgical maneuvers [10]. On the other hand, C-IONM is an ideal modality to monitor the intactness of the RLN and the VN because it offers real-time feedback to surgeons. In a C-IONM system, continuous automatic stimulation is applied to the VN, and the EMG signal evoked by the vocal cord is monitored via electrodes on the endotracheal tube [11]. This facilitates the early detection of adverse EMG changes and alerts surgeons of the need to suspend surgical maneuvers immediately, thus preventing nerve injury [12, 13]. However, C-IONM has several limitations. First, additional procedures are required to use this device: the carotid sheath should be dissected, the VN should be fully exposed, the VN should be lifted, and the stimulating device should be applied on the VN. Second, continuous VN stimulation can cause hemodynamic instability, although the risk is low [14]. Last, C-IONM is costly because a device which delivers electric current to the VN is required. Considering the low incidence of RLN palsy, C-IONM cannot be used in all thyroid surgery cases because it may not be cost-effective [15]. In order to continuously monitor the RLN during thyroid surgery, without the use of C-IONM devices, stimulators have been connected to surgical instruments used near the RLN, including dissecting forceps and an energy-based device [14, 16, 17]. Studies reported that the EMG amplitudes evoked by this approach were comparable with those of a conventional stimulator. Another recent study introduced a detachable magnetic stimulator which could be attached to any metallic surgical instrument. This study also reported comparable nerve stimulation amplitudes between the detachable magnetic stimulator and a conventional stimulator [18]. The ARS is advantageous during the thyroid surgery in terms of time saving. Although it still takes time to move the ARS from one instrument to the other when the surgeon wants to change dissecting surgical instruments, alternating between the nerve stimulator and the dissecting instrument is more time-consuming and cumbersome compared to ARS. If the dissecting instrument is connected to the stimulator, the surgeon can stimulate the RLN with the dissecting instrument more frequently, and the time interval between stimulations is reduced. When the RLN is located in an unexpected position and the risk of RLN injury is particularly high, such as with nonrecurrent or bifurcated RLN [19, 20], a stimulator-connected dissector is helpful to locate the RLN because the EMG signal can be detected during exploration, before visual identification. In addition, stretch injury during soft tissue dissection may be avoided because the RLN is monitored continuously while the soft tissue covering the RLN is dissected. If the RLN is overstretched during dissection, the EMG amplitude decreases below threshold, which alerts the surgeon of the pending RLN injury so that surgical maneuvers may be suspended. Likewise, if an energy-based device is applied to the soft tissue while spreading the soft tissue with the dissecting instruments, the thermal effect of the energy-based device on the RLN can be monitored. In this study, the amplitudes evoked by the ARS and the conventional stimulator were comparable. In addition, there are additional advantages related to the ARS used in the current study. The ARS can be easily attached to most surgical instruments (such as mosquito forceps, tonsil forceps, Mixter forceps, and Metzenbaum scissors) by tightening a rubber ring. The ARS was developed to monitor nerves originating from the spinal cord in spinal surgery and has been used following approval from the regulatory administrative body. Unlike other attachable stimulators, which cannot be used without approval from the local medical administrative body, the ARS used in this study is already commercialized and can be used without regulatory approval. As a disadvantage, stimulus cannot be delivered to the nerve if the rubber ring becomes loosened from the surgical instrument. Therefore, the tightness of the rubber ring should be closely monitored. The most common reason for IONM failure is malposition of the endotracheal tube [7]. In fact, upward or downward migration of the endotracheal tube by 1 cm can cause a significant decrease in EMG amplitude [21, 22]. During patient positioning, tube migration more than 1 cm occurs in 12.7% of the patients [23] and tube repositioning is required in 5% of patients [24]. In this study, prior to intubation, a pillow was placed beneath the patient's neck for neck extension to avoid tube displacement during patient positioning. In the current study, the EMG amplitudes of the RLN and VN were above 500 μV. There are limitations in the use of the ARS. First, the instruments used in this study had no insulation coating which resulted in electrical current shunting and no EMG response if the shaft of the instrument was in contact with skin or soft tissue while the surgeon stimulated the RLN with the tip of the instrument. Therefore, the surgeon used a high-stimulus current (2 or 3 mA) before visualizing the RLN and had to avoid touching the surrounding tissue during nerve stimulation. We propose that insulated instruments with the tip being only exposed should be developed for more effective stimulation. Second, the ARS basically facilitates I-IONM, although the surgeon can stimulate the RLN continuously around the RLN using the ARS and receive continuous feedback. The ARS only gives information about the integrity of the RLN distal to the stimulation point, and the integrity of the proximity to the stimulation point cannot be assessed. In addition, the amplitude may alter depending on the conditions such as the dissector's contacting area with the nerve or contact duration. Therefore, C-IONM, which monitors RLN integrity along its whole course of the neck by stimulating the VN is more effective than the ARS in terms of real-time evaluation of the traction injury. In addition, latency changes as a component of EMG changes in case of impending nerve injury cannot be determined with the ARS. Thus, the ARS may be inferior to C-IONM in terms of preventing tractional nerve injury.

5. Conclusions

This study demonstrated that ARS can be safely used for IONM during thyroid surgery and that the ARS transferred electric stimulation as effectively as a conventional stimulator. The ARS may be used to obtain real-time feedback about the functional status of the RLN during thyroid surgery.
  21 in total

1.  Intraoperative neuromonitoring for the early detection and prevention of RLN traction injury in thyroid surgery: a porcine model.

Authors:  Che-Wei Wu; Gianlorenzo Dionigi; Hui Sun; Xiaoli Liu; Hoon Yub Kim; Pi-Jung Hsiao; Kuo-Bow Tsai; Hui-Chun Chen; Hsiu-Ya Chen; Pi-Ying Chang; I-Cheng Lu; Feng-Yu Chiang
Journal:  Surgery       Date:  2013-09-29       Impact factor: 3.982

2.  Impact of positional changes in neural monitoring endotracheal tube on amplitude and latency of electromyographic response in monitored thyroid surgery: Results from the Porcine Experiment.

Authors:  Hoon Yub Kim; Ralph P Tufano; Gregory Randolph; Marcin Barczyński; Che-Wei Wu; Feng-Yu Chiang; Xiaoli Liu; Hiroo Masuoka; Akira Miyauchi; Soo Young Park; Hee Yong Kwak; Hye Yoon Lee; Gianlorenzo Dionigi
Journal:  Head Neck       Date:  2015-07-18       Impact factor: 3.147

3.  Changes in electromyographic amplitudes but not latencies occur with endotracheal tube malpositioning during intraoperative monitoring for thyroid surgery: Implications for guidelines.

Authors:  Samuel R Barber; Whitney Liddy; Natalia Kyriazidis; Matteo Cinquepalmi; Brian M Lin; Rahul Modi; Stephanie Patricio; Dipti Kamani; Carlo Belotti; Sadhana Mahamad; Bradley Lawson; Gregory W Randolph
Journal:  Laryngoscope       Date:  2016-11-16       Impact factor: 3.325

Review 4.  International neural monitoring study group guideline 2018 part I: Staging bilateral thyroid surgery with monitoring loss of signal.

Authors:  Rick Schneider; Gregory W Randolph; Gianlorenzo Dionigi; Che-Wei Wu; Marcin Barczynski; Feng-Yu Chiang; Zaid Al-Quaryshi; Peter Angelos; Katrin Brauckhoff; Claudio R Cernea; John Chaplin; Jonathan Cheetham; Louise Davies; Peter E Goretzki; Dana Hartl; Dipti Kamani; Emad Kandil; Natalia Kyriazidis; Whitney Liddy; Lisa Orloff; Joseph Scharpf; Jonathan Serpell; Jennifer J Shin; Catherine F Sinclair; Michael C Singer; Samuel K Snyder; Neil S Tolley; Sam Van Slycke; Erivelto Volpi; Ian Witterick; Richard J Wong; Gayle Woodson; Mark Zafereo; Henning Dralle
Journal:  Laryngoscope       Date:  2018-10-05       Impact factor: 3.325

5.  Thyroidectomy: prevention of bilateral recurrent nerve palsy. Results of identification of the nerve over 23 consecutive years (1946-69) with a description of an additional safety measure.

Authors:  V Riddell
Journal:  Br J Surg       Date:  1970-01       Impact factor: 6.939

6.  Feasibility and safety of nerve stimulator attachment to energy-based devices: A porcine model study.

Authors:  Sung-Chan Shin; Eui-Suk Sung; Sung-Won Choi; Sung-Dong Kim; Da-Woon Jung; Seok-Hyun Kim; Jung Hoon Ro; Jin-Choon Lee; Byung-Joo Lee
Journal:  Int J Surg       Date:  2017-10-31       Impact factor: 6.071

7.  Development of a Novel Detachable Magnetic Nerve Stimulator for Intraoperative Neuromonitoring.

Authors:  Eui-Suk Sung; Jin-Choon Lee; Sung-Chan Shin; Sung-Won Choi; Da-Woon Jung; Byung-Joo Lee
Journal:  World J Surg       Date:  2018-01       Impact factor: 3.352

8.  A prospective evaluation of recurrent laryngeal nerve paralysis during thyroidectomy.

Authors:  C Y Lo; K F Kwok; P W Yuen
Journal:  Arch Surg       Date:  2000-02

9.  Intraoperative neuromonitoring versus visual nerve identification for prevention of recurrent laryngeal nerve injury in adults undergoing thyroid surgery.

Authors:  Roberto Cirocchi; Alberto Arezzo; Vito D'Andrea; Iosief Abraha; Georgi I Popivanov; Nicola Avenia; Chiara Gerardi; Brandon Michael Henry; Justus Randolph; Marcin Barczyñski
Journal:  Cochrane Database Syst Rev       Date:  2019-01-19

10.  Comparing the safety of harmonic ACE and ACE+ around the recurrent laryngeal nerve in swine models.

Authors:  Hong Kyu Kim; Young Jun Chai; Hye Yoon Lee; Hoon Yub Kim; Gianlorenzo Dionigi
Journal:  Ann Surg Treat Res       Date:  2018-05-29       Impact factor: 1.859

View more
  3 in total

1.  Application of patch stimulator for intraoperative neuromonitoring during thyroid surgery: maximizing surgeon's convenience.

Authors:  Moon Young Oh; Jung-Man Lee; Myung-Ho Lee; Hyun Suk Choi; Jongjin Kim; Ki-Tae Hwang; Young Jun Chai
Journal:  Gland Surg       Date:  2021-08

2.  Administration of neostigmine after tracheal intubation shortens time to successful intraoperative neuromonitoring during thyroid surgery: a randomized controlled trial.

Authors:  Moon Young Oh; Young Jun Chai; Tzu-Yen Huang; Che-Wei Wu; Gianlorenzo Dionigi; Hoon Yub Kim; Chanho Kim; Dongwook Won; Jung-Man Lee
Journal:  Sci Rep       Date:  2022-10-07       Impact factor: 4.996

Review 3.  Informed Consent for Intraoperative Neural Monitoring in Thyroid and Parathyroid Surgery - Consensus Statement of the International Neural Monitoring Study Group.

Authors:  Che-Wei Wu; Tzu-Yen Huang; Gregory W Randolph; Marcin Barczyński; Rick Schneider; Feng-Yu Chiang; Amanda Silver Karcioglu; Beata Wojtczak; Francesco Frattini; Patrizia Gualniera; Hui Sun; Frank Weber; Peter Angelos; Henning Dralle; Gianlorenzo Dionigi
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-07       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.